How long after initiating mirtazapine therapy does appetite typically increase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mirtazapine Typically Increases Appetite Within 1-2 Weeks of Initiation

Mirtazapine's appetite-stimulating effects generally manifest within the first 1-2 weeks of treatment, with some patients experiencing increased appetite within days of starting therapy. This rapid onset distinguishes mirtazapine from its antidepressant effects, which typically require 4-8 weeks for full therapeutic benefit 1.

Timeline of Appetite Effects

The FDA label data demonstrates that increased appetite occurs in 17% of patients treated with mirtazapine compared to only 2% with placebo in 6-week controlled trials 2. Importantly, this side effect profile emerges early in treatment, as evidenced by clinical trial data showing appetite changes detected within the initial weeks of therapy.

Clinical Evidence on Timing

A controlled study in healthy men showed that hunger and appetite for sweets increased within 7 days of mirtazapine 30 mg daily, accompanied by metabolic shifts toward carbohydrate preference 3. This provides direct evidence that appetite stimulation occurs rapidly, independent of weight gain or depression improvement.

In cancer patients with anorexia, mirtazapine significantly increased energy intake by 379.3 kcal after 4 weeks of treatment 4, though appetite scores themselves did not differ from placebo. This suggests the appetite-stimulating effect manifests functionally (increased food intake) within the first month.

Dosing Considerations

The standard starting dose is 15 mg once daily at bedtime 5. The appetite-stimulating effect appears dose-related, as the FDA label notes this side effect across the therapeutic range. In the dementia literature, one retrospective study using 30 mg daily reported mean weight gain of 1.9 kg after 3 months 6, suggesting sustained appetite effects over time.

Mechanism and Clinical Context

Mirtazapine's appetite stimulation results from potent H1 histamine receptor antagonism and 5-HT2C receptor blockade, which occur immediately upon drug administration 5, 7. This pharmacological action is distinct from its antidepressant mechanism, explaining why appetite effects precede mood improvement.

Important Caveats

  • Somnolence occurs in 54% of patients 2 and typically manifests concurrently with appetite changes, both being early side effects
  • The appetite effect is not universal—only 17% of patients in trials reported increased appetite, though weight gain ≥7% occurred in 7.5% of patients 2
  • In palliative care settings, mirtazapine is recommended for appetite stimulation particularly when patients have concomitant sleep difficulties or mood disorders 7

Clinical Monitoring

Patients should be counseled that:

  • Appetite increase may occur within days to 2 weeks of starting treatment
  • Weight gain typically follows appetite changes, becoming measurable by 4-8 weeks
  • The effect is most pronounced at bedtime dosing due to concurrent sedation
  • Appetite for sweets and carbohydrates specifically may increase 3

The rapid onset of appetite stimulation (1-2 weeks) makes mirtazapine particularly useful when timely intervention for anorexia is needed, though guidelines note that for appetite stimulation alone (without depression), its use should be carefully considered given other side effects 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.